• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Point-An Important Diagnostic, Phenotypic, and Biomarker Role.

作者信息

Calais Jeremie, Mona Christine E

机构信息

Department of Molecular and Medical Pharmacology, Ahmanson Translational Theranostics Division, David Geffen School of Medicine, University of California Los Angeles, 200 Medical Plaza, Ste B114-61, Los Angeles, CA 90095.

Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA.

出版信息

AJR Am J Roentgenol. 2021 Feb;216(2):305-306. doi: 10.2214/AJR.20.24302. Epub 2020 Dec 23.

DOI:10.2214/AJR.20.24302
PMID:32755205
Abstract
摘要

相似文献

1
Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Point-An Important Diagnostic, Phenotypic, and Biomarker Role.未来十年，FAPI PET/CT会取代FDG PET/CT吗？观点——重要的诊断、表型及生物标志物作用
AJR Am J Roentgenol. 2021 Feb;216(2):305-306. doi: 10.2214/AJR.20.24302. Epub 2020 Dec 23.
2
Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Counterpoint-No, Not So Fast!在未来十年，FAPI PET/CT会取代FDG PET/CT吗？反对观点——不会，没那么快！
AJR Am J Roentgenol. 2021 Feb;216(2):307-308. doi: 10.2214/AJR.20.23794. Epub 2020 Dec 23.
3
Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.镓-FAPI PET/CT：不同癌症患者中两种含 DOTA 的 FAP 靶向剂的生物分布和初步剂量估算。
J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2.
4
Fibroblast Activation Protein-Targeted PET/CT with Ga-FAPI for Imaging IgG4-Related Disease: Comparison to F-FDG PET/CT.成纤维细胞激活蛋白靶向 PET/CT 联合 Ga-FAPI 对 IgG4 相关疾病的成像：与 F-FDG PET/CT 的比较。
J Nucl Med. 2021 Feb;62(2):266-271. doi: 10.2967/jnumed.120.244723. Epub 2020 Jun 8.
5
A comparative review of the application value of FAPI PET/CT and F-FDG PET/CT in lung cancer.FAPI PET/CT 与 F-FDG PET/CT 在肺癌中应用价值的对比研究
Hell J Nucl Med. 2024 May-Aug;27(2):131-135. doi: 10.1967/s002449912724. Epub 2024 Aug 6.
6
Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.镓-FAPI PET/CT：28 种不同癌症的示踪剂摄取。
J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.
7
Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool.成纤维细胞活化蛋白抑制剂 PET/CT：一种有前途的分子影像学工具。
Clin Nucl Med. 2021 Mar 1;46(3):e141-e150. doi: 10.1097/RLU.0000000000003489.
8
Diagnostic Performances of PET/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review.基于成纤维细胞激活蛋白抑制剂的 PET/CT 对原发性和转移性肝脏肿瘤患者的诊断性能：一项全面的文献综述。
Int J Mol Sci. 2024 Jun 29;25(13):7197. doi: 10.3390/ijms25137197.
9
Ga FAPI PET/CT Imaging in Peritoneal Carcinomatosis.镓标记的FAPI PET/CT成像在腹膜癌病中的应用
Radiology. 2020 Dec;297(3):521. doi: 10.1148/radiol.2020202469. Epub 2020 Oct 13.
10
The Application of [Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.[Ga]-标记 FAPI-04 PET/CT 在患者来源的原位异种移植模型中用于胰腺癌细胞靶向和早期检测的应用。
Contrast Media Mol Imaging. 2022 Aug 5;2022:6596702. doi: 10.1155/2022/6596702. eCollection 2022.

引用本文的文献

1
Enhanced Detection of Recurrent Diffuse Malignant Peritoneal Mesothelioma Using Ga-FAPI PET/CT Compared to F-FDG PET/CT: A Case Report.与¹⁸F-FDG PET/CT相比，¹⁸Ga-FAPI PET/CT在复发性弥漫性恶性腹膜间皮瘤检测中的应用：一例报告
World J Nucl Med. 2025 Mar 12;24(2):185-188. doi: 10.1055/s-0045-1805043. eCollection 2025 Jun.
2
Clinical significance of diffuse [F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging.PET/CT成像中甲状腺弥漫性[F]AlF-NOTA-FAPI-04摄取的临床意义。
EJNMMI Res. 2025 Apr 25;15(1):47. doi: 10.1186/s13550-025-01231-9.
3
Head-to-head comparison of [F]FAPI-42 and [F]FDG PET/CT in the evaluation of laryngeal squamous cell carcinoma.
[F]FAPI-42与[F]FDG PET/CT在喉鳞状细胞癌评估中的头对头比较。
Eur J Nucl Med Mol Imaging. 2025 Mar 8. doi: 10.1007/s00259-025-07180-8.
4
Impact of Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal F-FDG PET/CT Findings.镓标记的纤维肌动蛋白结合肽正电子发射断层扫描/计算机断层扫描（Ga-FAPi PET/CT）对¹⁸F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（¹⁸F-FDG PET/CT）结果为阴性或不确定的消化系统肿瘤患者分期或再分期的影响
Mol Imaging Radionucl Ther. 2025 Feb 7;34(1):31-37. doi: 10.4274/mirt.galenos.2024.50470.
5
Exploration the feasibility and additional value of [F]FDG/[Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [Ga]Ga-FAPI-04.在注射[镓]Ga-FAPI-04后34分钟，探索[氟]FDG/[镓]Ga-FAPI-04双低活度示踪剂一站式全身PET成像的可行性和附加价值。
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):638-647. doi: 10.1007/s00259-024-06924-2. Epub 2024 Sep 25.
6
The comparative utility of FAPI-based PET radiotracers over [F]FDG in the assessment of malignancies.基于FAPI的PET放射性示踪剂在恶性肿瘤评估中相对于[F]FDG的比较效用。
Am J Nucl Med Mol Imaging. 2024 Aug 25;14(4):190-207. doi: 10.62347/JXZI9315. eCollection 2024.
7
Head-to-head comparison of [Ga]Ga-FAPI-04 PET and [F]FDG PET in the detection of cancer recurrence: a systematic review and meta-analysis.[镓]Ga-FAPI-04 PET与[氟]FDG PET在检测癌症复发中的头对头比较：一项系统评价和荟萃分析。
Transl Cancer Res. 2024 Jun 30;13(6):2779-2789. doi: 10.21037/tcr-23-2296. Epub 2024 Jun 11.
8
Imaging Evaluation of Peritoneal Metastasis: Current and Promising Techniques.腹膜转移瘤的影像学评估：现有及有潜力的技术。
Korean J Radiol. 2024 Jan;25(1):86-102. doi: 10.3348/kjr.2023.0840.
9
F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with F-FDG PET/CT.F-FAPI PET/CT 在评估肺癌患者纵隔和肺门淋巴结方面表现更佳：与 F-FDG PET/CT 的比较。
Eur J Med Res. 2024 Jan 3;29(1):9. doi: 10.1186/s40001-023-01494-9.
10
Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment.治疗诊断应用的进展：探索成纤维细胞活化蛋白抑制示踪剂在增强甲状腺健康评估中的作用。
EJNMMI Res. 2023 Dec 22;13(1):109. doi: 10.1186/s13550-023-01060-8.